FI20145552A - conjugates - Google Patents

conjugates

Info

Publication number
FI20145552A
FI20145552A FI20145552A FI20145552A FI20145552A FI 20145552 A FI20145552 A FI 20145552A FI 20145552 A FI20145552 A FI 20145552A FI 20145552 A FI20145552 A FI 20145552A FI 20145552 A FI20145552 A FI 20145552A
Authority
FI
Finland
Prior art keywords
conjugates
Prior art date
Application number
FI20145552A
Other languages
Finnish (fi)
Swedish (sv)
Other versions
FI125971B (en
Inventor
Anne Leppänen
Filip S Ekholm
Jari Helin
Original Assignee
Tenboron Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FI20145552A priority Critical patent/FI125971B/en
Application filed by Tenboron Oy filed Critical Tenboron Oy
Priority to AU2015273353A priority patent/AU2015273353B2/en
Priority to CN201580031651.XA priority patent/CN106456768B/en
Priority to PCT/FI2015/050422 priority patent/WO2015189477A1/en
Priority to JP2015119792A priority patent/JP5924795B2/en
Priority to CA2952026A priority patent/CA2952026A1/en
Priority to US15/318,030 priority patent/US10328149B2/en
Priority to ES15734421T priority patent/ES2779974T3/en
Priority to EP15734421.9A priority patent/EP3154587B1/en
Priority to DK15734421.9T priority patent/DK3154587T3/en
Publication of FI20145552A publication Critical patent/FI20145552A/en
Application granted granted Critical
Publication of FI125971B publication Critical patent/FI125971B/en
Priority to US16/383,832 priority patent/US10835606B2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/009—Neutron capture therapy, e.g. using uranium or non-boron material
    • A61K41/0095—Boron neutron capture therapy, i.e. BNCT, e.g. using boronated porphyrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
    • A61K47/6835—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
    • A61K47/6851—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a determinant of a tumour cell
    • A61K47/6865—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a determinant of a tumour cell the tumour determinant being from skin, nerves or brain cancer cell

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cell Biology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Oncology (AREA)
  • Immunology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
FI20145552A 2014-06-13 2014-06-13 conjugates FI125971B (en)

Priority Applications (11)

Application Number Priority Date Filing Date Title
FI20145552A FI125971B (en) 2014-06-13 2014-06-13 conjugates
CN201580031651.XA CN106456768B (en) 2014-06-13 2015-06-12 Conjugate containing anti-EGFR1 antibody
PCT/FI2015/050422 WO2015189477A1 (en) 2014-06-13 2015-06-12 Conjugates comprising an anti-egfr1 antibody
JP2015119792A JP5924795B2 (en) 2014-06-13 2015-06-12 Complex
AU2015273353A AU2015273353B2 (en) 2014-06-13 2015-06-12 Conjugates comprising an anti-EGFR1 antibody
CA2952026A CA2952026A1 (en) 2014-06-13 2015-06-12 Conjugates comprising an anti-egfr1 antibody
US15/318,030 US10328149B2 (en) 2014-06-13 2015-06-12 Conjugates comprising an anti-EGFR1 antibody
ES15734421T ES2779974T3 (en) 2014-06-13 2015-06-12 Conjugates comprising an anti-egfr1 antibody
EP15734421.9A EP3154587B1 (en) 2014-06-13 2015-06-12 Conjugates comprising an anti-egfr1 antibody
DK15734421.9T DK3154587T3 (en) 2014-06-13 2015-06-12 CONJUGATES INCLUDING AN ANTI-EGFR1 ANTIBODY
US16/383,832 US10835606B2 (en) 2014-06-13 2019-04-15 Conjugates comprising an anti-EGFR1 antibody

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FI20145552A FI125971B (en) 2014-06-13 2014-06-13 conjugates

Publications (2)

Publication Number Publication Date
FI20145552A true FI20145552A (en) 2015-12-14
FI125971B FI125971B (en) 2016-05-13

Family

ID=55917262

Family Applications (1)

Application Number Title Priority Date Filing Date
FI20145552A FI125971B (en) 2014-06-13 2014-06-13 conjugates

Country Status (1)

Country Link
FI (1) FI125971B (en)

Also Published As

Publication number Publication date
FI125971B (en) 2016-05-13

Similar Documents

Publication Publication Date Title
DK3268047T3 (en) AMATOXIN/ANTISTOF CONJUGATES
DK3119885T3 (en) Antibody-fynomer conjugates
DK3183051T3 (en) LIQUID-TO-LUFTMEMBRANENERGIVEKSLERE
DK3134402T3 (en) 4-amino-imidazoquinoline
DK3466976T3 (en) ANTI-HER2-ANTIBODY-MEDICINE CONJUGATE
DK3211743T3 (en) E-to-network omskiftningsfremgangsmåde
DK3137114T3 (en) Anti-PTK7 antibody-drug conjugates
DK3148591T3 (en) Nanoparticle-drug conjugates
DK3119396T3 (en) MUSCARINRECEPTORAGONISTER
DK3006072T3 (en) Karadgang
DE112015001664A5 (en) Betätigungsaktuator
DK3183340T3 (en) TERMOLABILE EXONUCLEASER
DK3154703T3 (en) FULLKAPPE-SNEKKECENTRIFUGE
DK3110439T3 (en) PCSK9-VACCINES
DE112015005041A5 (en) GARGERÄTEVORRICHTUNG
DE102014000623A8 (en) Halbhohlnietelement
DK3009858T3 (en) SKYRADAR
DE112015001633A5 (en) Betätigungsaktuator
DK3447493T3 (en) PROTEIN-ORATED ORTHOLOGISTS
DK3091875T3 (en) VIPBAR TABURET
DE202014005655U8 (en) llluminationsvorrichtung
FI20145552A (en) conjugates
DE112015005055A5 (en) Gargerätevorrichtung
DK3191825T3 (en) CREATININBIOSENSOR
FI10894U1 (en) Rörisoleringsränna

Legal Events

Date Code Title Description
PC Transfer of assignment of patent

Owner name: TENBORON OY

FG Patent granted

Ref document number: 125971

Country of ref document: FI

Kind code of ref document: B